CPIX - Cumberland Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
80.63M
Enterprise Value 3
72.29M
Trailing P/E
N/A
Forward P/E 1
53.10
PEG Ratio (5 yr expected) 1
0.72
Price/Sales (ttm)
1.70
Price/Book (mrq)
1.56
Enterprise Value/Revenue 3
1.53
Enterprise Value/EBITDA 6
-98.40

Trading Information

Stock Price History

Beta (3Y Monthly) 0.12
52-Week Change 3-16.64%
S&P500 52-Week Change 318.89%
52 Week High 36.99
52 Week Low 34.19
50-Day Moving Average 35.21
200-Day Moving Average 35.60

Share Statistics

Avg Vol (3 month) 326.71k
Avg Vol (10 day) 313.33k
Shares Outstanding 515.18M
Float 7.89M
% Held by Insiders 142.13%
% Held by Institutions 132.52%
Shares Short (Nov 15, 2019) 490.3k
Short Ratio (Nov 15, 2019) 47.5
Short % of Float (Nov 15, 2019) 41.00%
Short % of Shares Outstanding (Nov 15, 2019) 40.59%
Shares Short (prior month Oct 15, 2019) 490.72k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Jul 6, 2007

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin -10.13%
Operating Margin (ttm)-10.32%

Management Effectiveness

Return on Assets (ttm)-3.20%
Return on Equity (ttm)-8.77%

Income Statement

Revenue (ttm)47.35M
Revenue Per Share (ttm)3.06
Quarterly Revenue Growth (yoy)22.10%
Gross Profit (ttm)33.36M
EBITDA -734.67k
Net Income Avi to Common (ttm)-4.8M
Diluted EPS (ttm)-0.32
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)29.24M
Total Cash Per Share (mrq)1.93
Total Debt (mrq)23.21M
Total Debt/Equity (mrq)44.89
Current Ratio (mrq)2.35
Book Value Per Share (mrq)3.40

Cash Flow Statement

Operating Cash Flow (ttm)5.92M
Levered Free Cash Flow (ttm)-694.03k